Discover 3,465 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,465
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Location: Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05836324
Phase1, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Los Angeles CA, La Jolla CA, Palo Alto CA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Location: Los Angeles CA, Stanford CA, Houston TX, Louisville KY,
Sponsor: Obsidian Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06060613
Phase1, Phase2, Recruiting
SNV4818 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Houston TX, Nashville TN, Toronto,
Sponsor: Pikavation Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06736704
Phase1, Phase2, Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
for
Melanoma Stage IV, Solid Tumor
Location: Los Angeles CA, Fullerton CA, Bakersfield CA,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06425926
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
for
Advanced Solid Malignancies
Location: Los Angeles CA, San Francisco CA, Irving TX, Dallas TX,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06028074
Phase1, Phase2, Recruiting
Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors
for
Stage III Melanoma, Stage IV Melanoma
Location: Los Angeles CA, Denver CO
Sponsor: Taiga Biotechnologies, Inc.
Sex: All
Age: 18+
Code: NCT03385486
Phase1, Recruiting
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
for
Solid Tumor, Adult, Refractory Cancer,
Location: Los Angeles CA, Portland OR, Houston TX,
Sponsor: GV20 Therapeutics
Sex: All
Age: 18+
Code: NCT05669430
Phase1, Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
for
Unresectable Melanoma, Metastatic Melanoma,
Location: Los Angeles CA, Westwood KS, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT05361174
Phase1, Phase2, Recruiting
First In Human Study of CX-801 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Los Angeles CA, Englewood CO, Fort Worth TX,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06462794
Phase1, Recruiting
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Los Angeles CA, Chicago IL, Tampa FL, New Hyde Park NY
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06121180
Phase2, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Los Angeles CA, Orange CA, La Jolla CA, Palo Alto CA,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
A Study of NTX-1472 in Social Anxiety Disorder
for
Social Anxiety Disorder (SAD)
Location: Los Angeles CA, Encino CA, Oceanside CA, San Jose CA,
Sponsor: Newleos Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07323784
Phase2, Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT04913285
Phase1, Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Irvine CA, Seattle WA, Charlotte NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06697197
Phase1, Phase2, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer